Video & interview archive

Presentation of Year-end report 2024

Corporate presentation by CEO Martin Welschof
December 17, 2024

CEO interview by Kelly Connelin, analyst at EFN (One of Sweden’s premier financial news channels), October 31, 2024.

Interim report January–September 2024, October 31, 2024.

Aktiedagen in Stockholm, September 18, 2024 Martin Welschof, vd

Redeye interview with CEO Martin Welschof and CMO Andres McAllister. September 11, 2024.

KOL event, June 18, 2024 featuring Professor Alexander Eggermont and presentations from the BioInvent management team (picture showing CMO Andres McAllister and CSO Björn Frendéus).

Listen to CEO Martin Welschof at the Investing in Oncology Forum, April 10, 2024

View CMO Andres McAllister’s presentation at Life Science Day 2024 at Sahlgrenska Science Park, Gothenburg

CEO Martin Welschof at Carnegie Healthcare Seminar March 6, 2024 
Password to watch video: Healthcare2024

Listen to CMO Andres McAllister talking about the I-O field, with a focus on the anti-TNFR2 antibody BI-1808. January 24, 2024.

ProHearings. Corporate presentation by CEO Martin Welschof December 17, 2024

Presentation of Year-end report 2023 (webcast)

BioStock Life Science Summit, October 26, 2023

Dec 11: Interview with CEO Martin Welschof and CMO Andres McAllister about BI-1607

Sep 6: Börsveckan’s Småbolagsdag

Aug 30: Interview with CEO Martin Welschof

Jun 13: Aktiespararna’s event Småbolagsdagen

Jun 8: Listen to CEO Martin Welschof presenting at the Jefferies Healthcare Conference in New York

Redeye Life Science Day 2022

Dec 8: R&D Day